Guidelines for Using Amitriptyline (Tricyclic Antidepressant)
Amitriptyline is recommended at low initial doses (10-25 mg daily) with gradual titration based on indication, with most therapeutic effects achieved at 25-75 mg daily for pain conditions and up to 150 mg daily for depression. 1
Indications and Dosing
Neuropathic Pain
- Starting dose: 10-25 mg once daily at bedtime
- Target dose: 25-75 mg daily
- Titration: Increase by 10-25 mg every 3-5 days until pain relief or side effects occur 2, 1
- Duration: Effective analgesic effects may be seen within the first week 3
- Evidence: Achieves good to moderate response in up to two-thirds of patients with post-herpetic neuralgia and three-quarters with painful diabetic neuropathy 4
Central Post-Stroke Pain
- Starting dose: 10-25 mg at bedtime
- Target dose: 75 mg at bedtime
- Evidence: Shown to lower daily pain ratings and improve global functioning 2
Irritable Bowel Syndrome (IBS)
- Starting dose: 10 mg at bedtime
- Target dose: 10-30 mg daily (self-titrated)
- Evidence: Significantly improves global IBS symptoms compared to placebo 5
- Best for: IBS with diarrhea (IBS-D) due to anticholinergic effects 2, 6
- Avoid in: IBS with constipation as primary symptom 6
Depression
- Outpatients: 75 mg daily in divided doses, may increase to 150 mg daily
- Hospitalized patients: 100 mg daily initially, may increase to 200-300 mg daily if necessary
- Elderly/Adolescents: 10 mg three times daily with 20 mg at bedtime 1
- Maintenance: 50-100 mg daily, often given as single bedtime dose 1
Cyclic Vomiting Syndrome
- Indication: Moderate-severe CVS (≥4 episodes/year, each lasting >2 days) 2
- Dosing: Starting at 25 mg at bedtime, with goal of 75-150 mg or 1-1.5 mg/kg at bedtime 2
Insomnia
- Off-label use: 10-20 mg at bedtime
- Evidence: 73.9% of patients report improved sleep maintenance 7
Administration Guidelines
- Time of administration: Preferably at bedtime to minimize daytime sedation 1
- Titration: Slow titration (10-25 mg increments every 2 weeks) is better tolerated 6
- Duration: For chronic conditions, maintain therapy for at least 3 months to reduce relapse risk 1
- Monitoring: Follow up in 4-6 weeks to assess symptom improvement and side effects 6
Side Effects Management
Common Side Effects (66.1% report at least one) 7
- Anticholinergic effects: Dry mouth, blurred vision, constipation, urinary retention
- CNS effects: Sedation, dizziness
- Cardiovascular: Orthostatic hypotension, tachycardia
Management Strategies
- For dry mouth: Frequent sips of water, sugar-free gum/candy, artificial saliva products 6
- For constipation: Increase dietary fiber, ensure adequate hydration, consider stool softeners 6
- For sedation: Bedtime dosing, start with lower doses in elderly 1
Special Populations
Elderly Patients
- Starting dose: Lower doses (10 mg at bedtime)
- Titration: More gradual titration
- Monitoring: Closer monitoring for anticholinergic side effects and orthostatic hypotension 6, 1
- Consideration: May have greater response to amitriptyline than younger patients 6
Pediatric Patients
- Not recommended for patients under 12 years of age due to lack of experience 1
Precautions and Contraindications
Cardiovascular
- Use with caution in patients with cardiovascular disorders
- Monitor closely: Can produce arrhythmias, sinus tachycardia, and prolonged conduction time 1
Other Precautions
- Seizure history: Use with caution due to lowered seizure threshold
- Glaucoma: Use with caution; may precipitate angle-closure glaucoma attacks
- Urinary retention: Use with caution due to anticholinergic effects
- Hyperthyroidism: Close supervision required 1
Suicide Risk
- Monitor closely for clinical worsening, suicidality, or unusual behavior changes, especially during initial few months of therapy or dose changes
- Higher risk in children, adolescents, and young adults with MDD or other psychiatric disorders 1
Drug Interactions
- Alcohol/CNS depressants: May enhance response to alcohol and effects of barbiturates
- Guanethidine: May block antihypertensive action
- Disulfiram: Delirium reported with concurrent administration 1
Amitriptyline remains an effective treatment option for multiple conditions when used appropriately, with careful dose titration and monitoring for side effects. Despite limited high-quality evidence for some indications, decades of clinical experience support its continued use, particularly for neuropathic pain conditions 8.